U.S. markets open in 8 hours 33 minutes

Quanta, Inc. (QNTA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0490-0.0003 (-0.61%)
At close: 3:58PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0493
Open0.0490
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0472 - 0.0500
52 Week Range0.0150 - 0.2050
Volume743,977
Avg. Volume7,891,672
Market Cap7.114M
Beta (5Y Monthly)1.79
PE Ratio (TTM)N/A
EPS (TTM)-0.0090
Earnings DateJun 19, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Medolife Rx Schedules Investor Webcast for Tuesday, July 27, 2021
    GlobeNewswire

    Medolife Rx Schedules Investor Webcast for Tuesday, July 27, 2021

    BURBANK, CA, July 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that it will hold a webcast and Q&A with the investment community on Tuesday, July 27, at 5 p.m. Eastern Daylight Time. The purpose of this is to answer questions received from the investment community all at one t

  • Medolife Rx Announces Donation of Escozine to Heath Clinic in Dominican Republic for Use on Growing COVID-19 Positive Patient Population
    GlobeNewswire

    Medolife Rx Announces Donation of Escozine to Heath Clinic in Dominican Republic for Use on Growing COVID-19 Positive Patient Population

    BURBANK, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that it is making significant donations of its lead drug candidate Escozine®, which was recently re-registered as a natural alternative medicine in the Dominican Republic (DR), to the Cruz Jiminian Foundat

  • Medolife Rx Clinical Observations Demonstrates Effectiveness of Escozine in Complementary Use with COVID-19 Vaccines
    GlobeNewswire

    Medolife Rx Clinical Observations Demonstrates Effectiveness of Escozine in Complementary Use with COVID-19 Vaccines

    BURBANK, Calif., July 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today new clinical observations made on its lead drug candidate Escozine®. Physicians observed that patients who originally had strong adverse reactions to COVID-19 vaccines and who were given Escozine®, experie